Invention Grant
- Patent Title: Dioxolane analogues of uridine for the treatment of cancer
-
Application No.: US16208083Application Date: 2018-12-03
-
Publication No.: US10336780B2Publication Date: 2019-07-02
- Inventor: Richard Bethell , Anders Eneroth , Bjorn Klasson , Fredrik Oberg
- Applicant: MEDIVIR AB
- Applicant Address: SE Stockholm
- Assignee: MEDIVIR AB
- Current Assignee: MEDIVIR AB
- Current Assignee Address: SE Stockholm
- Agency: Gorman IP Law, APC
- Priority: SE1450983 20140825; SE1550858 20150622
- Main IPC: C07D405/04
- IPC: C07D405/04 ; C07F9/6558 ; A61K45/06 ; A61K31/675 ; C07F9/24 ; A61K31/506

Abstract:
The invention provides compounds of the formula: R1 is OR11, or NR5R5′;R2 is H or F;R5 is H, C1-C6alkyl, OH, C(═O)R6, O(C═O)R6 or O(C═O)OR6;R5 is H or C1-C6alkyl;R6 is C1-C6alkyl or C3-C7cycloalkyl;R13 is H, phenyl, pyridyl, benzyl, indolyl or naphthyl wherein the phenyl, pyridyl, benzyl, indolyl and naphthyl is optionally substituted with 1, 2 or 3 R22;and the other variables are as defined in the claims,which are of use in the treatment of cancer, and related aspects.
Public/Granted literature
- US20190100541A1 DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER Public/Granted day:2019-04-04
Information query